BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Micell Technologies And Pacific Northwest National Laboratories Expand Research Collaboration Involving Supercritical Fluid Technology


8/10/2006 11:39:31 AM

RALEIGH, N.C., Aug. 9 /PRNewswire/ -- Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle. Under the expansion of the agreement, research will focus on additional applications of the award winning e-RESS technology for creating drug-eluting coatings for cardiovascular stents.

The e-RESS (e for electrostatic, RESS for Rapid Expansion from Supercritical Solution) innovation involves electrostatic capture and deposition of micro and nanoparticles onto the surface of a medical device using supercritical fluids. Scientists at Micell and PNNL were recently honored with a prestigious R&D 100 Award recognizing the technology as one of the 100 most important scientific and technical innovations for 2006. The e-RESS technology has been exclusively licensed to Micell from PNNL, and all product developed through this expanded agreement will be licensed to Micell under the terms of the current agreement.

"Combining PNNL's expertise in supercritical fluid technology with our internal expertise creates a powerful combination for continued development of this unique medical device surface modification technology," said Arthur J. Benvenuto, Chairman and Chief Executive Officer of Micell Technologies. "Micell's processes utilizing the e-RESS technology create an opportunity to deliver the next generation of drug-eluting stents, and to provide the potential for further important advances to the medical device marketplace."

About Pacific Northwest National Laboratory

Pacific Northwest National Laboratory (PNNL) is a Department Of Energy, Office of Science laboratory that solves complex problems in energy, national security, the environment and life sciences by advancing the understanding of physics, chemistry, biology and computation. PNNL employs 4,200 staff, has an annual budget of more than $725 million, and has been managed by Ohio-based Battelle since the lab's inception in 1965. To learn more, please visit PNNL's website at www.pnl.gov/

About Micell

Micell Technologies is a privately-held, early-stage biomedical company dedicated to advancing combination product therapies in the cardiovascular, orthopedic, and drug-delivery areas. The Company's patented processes and methods for medical device surface modification using supercritical fluids are focused on improvements to current polymer based drug-eluting technologies. To learn more, please visit our website at www.micell.com

Micell Technologies

CONTACT: James McClain Ph.D., Chief Technology Officer of MicellTechnologies, +1-919-313-2111; or Mary Anne Wuennecke, Media Relations ofPacific Northwest National Laboratory, +1-509-375-2447



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES